Home › Funds › NEA Management Company, LLC › SNTI
NEA Management Company, LLC position in SNTI
Senti Biosciences Holdings Inc · Health Care
NEA Management Company, LLC reported holding 3,775,615 shares of SNTI (Senti Biosciences Holdings Inc) in its Q2 2026 13F filing — a position valued at US$4.2M, representing 0.26% of its reported portfolio and ranking #22 among its reported holdings. NEA Management Company, LLC has disclosed SNTI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How NEA Management Company, LLC's SNTI position evolved
NEA Management Company, LLC first disclosed a stake in SNTI in Q3 2023 at 4,426,151 shares (US$1.8M). The position peaked in Q1 2025 at 3,775,615 shares, worth US$12.7M. Across 12 filings, NEA Management Company, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 3,775,615 shares valued at US$4.2M. Notable position changes include a 90% trim in Q3 2024 (shares rose 55% over the following quarter), a 753% increase in Q1 2025 (shares fell 37% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.43M | $1.83M | New |
| Q4 2023 | 4.43M | $2.92M | Hold |
| Q1 2024 | 4.43M | $1.67M | Hold |
| Q2 2024 | 4.43M | $1.22M | Hold |
| Q3 2024 | 442.62K | $1.00M | Reduce |
| Q4 2024 | 442.62K | $1.55M | Hold |
| Q1 2025 | 3.78M | $12.69M | Add |
| Q2 2025 | 3.78M | $7.97M | Hold |
| Q3 2025 | 3.78M | $5.32M | Hold |
| Q4 2025 | 3.78M | $3.93M | Hold |
| Q1 2026 | 3.78M | $3.07M | Hold |
| Q2 2026 | 3.78M | $4.15M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SNTI and 13F data
SNTI (Senti Biosciences Holdings Inc) is a Health Care company. 20 other funds we track also report a position in SNTI — the largest reported positions include Menlo Ventures Management, L.P. (US$39K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SNTI
- Menlo Ventures Management, L.P. 35.74K sh · $39.31K · Q2 2026
More on NEA Management Company, LLC
FAQ
How long has NEA Management Company, LLC held SNTI?
NEA Management Company, LLC has disclosed SNTI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is NEA Management Company, LLC's current position in SNTI?
As of Q2 2026, NEA Management Company, LLC holds 3.78M shares of SNTI (Senti Biosciences Holdings Inc), valued at $4.15M, representing 0.26% of its reported portfolio and ranking #22.
Has NEA Management Company, LLC been buying or selling SNTI?
In the latest 13F filing (Q2 2026), NEA Management Company, LLC held unchanged its position in SNTI. The position peaked in Q1 2025 at 3.78M shares.
Which other funds hold SNTI?
Other major institutional holders of SNTI include Menlo Ventures Management, L.P., among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.